Divergent Allele Advantage at Human MHC Genes: Signatures of Past and Ongoing Selection
- PMID: 29893875
- PMCID: PMC6106954
- DOI: 10.1093/molbev/msy116
Divergent Allele Advantage at Human MHC Genes: Signatures of Past and Ongoing Selection
Abstract
The highly polymorphic genes of the major histocompatibility complex (MHC) play a key role in adaptive immunity. Divergent allele advantage, a mechanism of balancing selection, is proposed to contribute to their exceptional polymorphism. It assumes that MHC genotypes with more divergent alleles allow for broader antigen-presentation to immune effector cells, by that increasing immunocompetence. However, the direct correlation between pairwise sequence divergence and the corresponding repertoire of bound peptides has not been studied systematically across different MHC genes. Here, we investigated this relationship for five key classical human MHC genes (human leukocyte antigen; HLA-A, -B, -C, -DRB1, and -DQB1), using allele-specific computational binding prediction to 118,097 peptides derived from a broad range of human pathogens. For all five human MHC genes, the genetic distance between two alleles of a heterozygous genotype was positively correlated with the total number of peptides bound by these two alleles. In accordance with the major antigen-presentation pathway of MHC class I molecules, HLA-B and HLA-C alleles showed particularly strong correlations for peptides derived from intracellular pathogens. Intriguingly, this bias coincides with distinct protein compositions between intra- and extracellular pathogens, possibly suggesting adaptation of MHC I molecules to present specifically intracellular peptides. Eventually, we observed significant positive correlations between an allele's average divergence and its population frequency. Overall, our results support the divergent allele advantage as a meaningful quantitative mechanism through which pathogen-mediated selection leads to the evolution of MHC diversity.
Keywords: HLA; balancing selection; heterozygote advantage; human evolution; pathogen-mediated selection.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.
Figures




Similar articles
-
Unique Pathogen Peptidomes Facilitate Pathogen-Specific Selection and Specialization of MHC Alleles.Mol Biol Evol. 2021 Sep 27;38(10):4376-4387. doi: 10.1093/molbev/msab176. Mol Biol Evol. 2021. PMID: 34110412 Free PMC article.
-
HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation.Mol Biol Evol. 2020 Mar 1;37(3):639-650. doi: 10.1093/molbev/msz249. Mol Biol Evol. 2020. PMID: 31651980 Free PMC article.
-
Computational prediction of MHC II-antigen binding supports divergent allele advantage and explains trans-species polymorphism.Evolution. 2011 Aug;65(8):2380-90. doi: 10.1111/j.1558-5646.2011.01288.x. Epub 2011 Apr 20. Evolution. 2011. PMID: 21790583
-
Do infectious diseases drive MHC diversity?Microbes Infect. 2000 Sep;2(11):1335-41. doi: 10.1016/s1286-4579(00)01287-9. Microbes Infect. 2000. PMID: 11018450 Review.
-
Advances in the Evolutionary Understanding of MHC Polymorphism.Trends Genet. 2020 Apr;36(4):298-311. doi: 10.1016/j.tig.2020.01.008. Epub 2020 Feb 7. Trends Genet. 2020. PMID: 32044115 Review.
Cited by
-
Salmonid Antibacterial Immunity: An Aquaculture Perspective.Biology (Basel). 2020 Oct 11;9(10):331. doi: 10.3390/biology9100331. Biology (Basel). 2020. PMID: 33050557 Free PMC article. Review.
-
HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation.Cancers (Basel). 2020 Jul 8;12(7):1835. doi: 10.3390/cancers12071835. Cancers (Basel). 2020. PMID: 32650450 Free PMC article.
-
Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer.Genome Med. 2021 Nov 3;13(1):175. doi: 10.1186/s13073-021-00997-6. Genome Med. 2021. PMID: 34732240 Free PMC article.
-
The HLA diversity of the Anthony Nolan register.HLA. 2021 Jan;97(1):15-29. doi: 10.1111/tan.14127. Epub 2020 Nov 16. HLA. 2021. PMID: 33128327 Free PMC article.
-
Evidence for Pathogen-Driven Selection Acting on HLA-DPB1 in Response to Plasmodium falciparum Malaria in West Africa.Ecol Evol. 2025 Feb 24;15(2):e70933. doi: 10.1002/ece3.70933. eCollection 2025 Feb. Ecol Evol. 2025. PMID: 40008064 Free PMC article.
References
-
- Beck S, Trowsdale J.. 2000. The human major histocompatibility complex: lessons from the DNA sequence. Annu Rev Genomics Hum Genet. 11:117–137. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous